微小RNA-107通过靶向非小细胞肺癌中的抗凋亡因子Bcl-w增强对紫杉醇的化疗敏感性。
MiRNA-107 enhances chemosensitivity to paclitaxel by targeting antiapoptotic factor Bcl-w in non small cell lung cancer.
作者信息
Lu Chaojing, Xie Zhibing, Peng Qingzhen
机构信息
Department of Thoracic Surgery, Changhai HospitalShanghai, China.
Department of Respiratory Medicine, Xiaogan Central Hospital, Wuhan University of Science and TechnologyXiaogan, China.
出版信息
Am J Cancer Res. 2017 Sep 1;7(9):1863-1873. eCollection 2017.
Abstract
The aim of this study is to elucidate whether and how miR-107 participates in the modulation of paclitaxel sensitivity in non small cell lung cancer (NSCLC). By qRT-PCR, we found that miR-107 is significantly down-regulated in paclitaxel-resistant A549/Taxol cells compared with corresponding paclitaxel-sensitive counterparts. Overexpression of miR-107 suppresses paclitaxel resistance of A549/Taxol cells through directly inhibiting Bcl-w. Overexpression of miR-107 promotes apoptosis and inhibits proliferation and mobility of A549/Taxol cells under treatment with paclitaxel . Moreover, miR-107 inhibits paclitaxel resistance in xenograft model. MiR-107/Bcl-w axis regulates paclitaxel chemoresistance through PI3K-Akt pathway. Our results suggest that up-regulation of miR-107 resensitizes paclitaxel-resistant NSCLC cells by targeting Bcl-w, which reveals a potential mechanism of miR-107 in reversing drug resistance.
摘要
本研究旨在阐明miR-107是否以及如何参与非小细胞肺癌（NSCLC）中紫杉醇敏感性的调节。通过qRT-PCR，我们发现与相应的紫杉醇敏感细胞相比，miR-107在紫杉醇耐药的A549/Taxol细胞中显著下调。miR-107的过表达通过直接抑制Bcl-w来抑制A549/Taxol细胞的紫杉醇耐药性。miR-107的过表达促进了紫杉醇处理下A549/Taxol细胞的凋亡，抑制了其增殖和迁移。此外，miR-107在异种移植模型中抑制紫杉醇耐药性。miR-107/Bcl-w轴通过PI3K-Akt途径调节紫杉醇化疗耐药性。我们的结果表明，miR-107的上调通过靶向Bcl-w使紫杉醇耐药的NSCLC细胞重新敏感，这揭示了miR-107在逆转耐药性中的潜在机制。
相似文献
1
MiRNA-107 enhances chemosensitivity to paclitaxel by targeting antiapoptotic factor Bcl-w in non small cell lung cancer.微小RNA-107通过靶向非小细胞肺癌中的抗凋亡因子Bcl-w增强对紫杉醇的化疗敏感性。
Am J Cancer Res. 2017 Sep 1;7(9):1863-1873. eCollection 2017.
2
miR-30a-5p enhances paclitaxel sensitivity in non-small cell lung cancer through targeting BCL-2 expression.微小RNA-30a-5p通过靶向B细胞淋巴瘤-2（BCL-2）的表达增强非小细胞肺癌对紫杉醇的敏感性。
J Mol Med (Berl). 2017 Aug;95(8):861-871. doi: 10.1007/s00109-017-1539-z. Epub 2017 May 9.
3
MicroRNA-424-5p enhances chemosensitivity of breast cancer cells to Taxol and regulates cell cycle, apoptosis, and proliferation.miR-424-5p 增强乳腺癌细胞对紫杉醇的化疗敏感性，并调节细胞周期、凋亡和增殖。
Mol Biol Rep. 2021 Feb;48(2):1345-1357. doi: 10.1007/s11033-021-06193-4. Epub 2021 Feb 8.
4
Circular RNA hsa_circ_0011298 enhances Taxol resistance of non-small cell lung cancer by regulating miR-486-3p/CRABP2 axis.环状 RNA hsa_circ_0011298 通过调控 miR-486-3p/CRABP2 轴增强非小细胞肺癌对紫杉醇的耐药性。
J Clin Lab Anal. 2022 May;36(5):e24408. doi: 10.1002/jcla.24408. Epub 2022 Apr 8.
5
Circular RNA circ_0002360 regulates the Taxol resistance and malignant behaviors of Taxol-resistant non-small cell lung cancer cells by microRNA-585-3p-dependent modulation of G protein regulated inducer of neurite outgrowth 1.环状 RNA circ_0002360 通过 microRNA-585-3p 依赖性调控 G 蛋白调节的神经突生长诱导因子 1 来调节紫杉醇耐药的非小细胞肺癌细胞的紫杉醇耐药性和恶性行为。
Bioengineered. 2022 Apr;13(4):9070-9085. doi: 10.1080/21655979.2022.2053803.
6
miR-186 regulates chemo-sensitivity to paclitaxel via targeting MAPT in non-small cell lung cancer (NSCLC).微小RNA-186通过靶向微管相关蛋白tau调控非小细胞肺癌对紫杉醇的化疗敏感性。
Mol Biosyst. 2016 Oct 18;12(11):3417-3424. doi: 10.1039/c6mb00576d.
7
MiR-16 targets Bcl-2 in paclitaxel-resistant lung cancer cells and overexpression of miR-16 along with miR-17 causes unprecedented sensitivity by simultaneously modulating autophagy and apoptosis.微小RNA-16在耐紫杉醇肺癌细胞中靶向Bcl-2，微小RNA-16与微小RNA-17一起过表达通过同时调节自噬和凋亡导致前所未有的敏感性。
Cell Signal. 2015 Feb;27(2):189-203. doi: 10.1016/j.cellsig.2014.11.023. Epub 2014 Nov 27.
8
MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer.微小RNA-137抑制肺癌肿瘤生长并增强对紫杉醇和顺铂的化疗敏感性。
Oncotarget. 2016 Apr 12;7(15):20728-42. doi: 10.18632/oncotarget.8011.
9
MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression.微小RNA-125b通过抑制促凋亡的Bcl-2拮抗剂杀手1（Bak1）的表达赋予乳腺癌细胞对紫杉醇的抗性。
J Biol Chem. 2010 Jul 9;285(28):21496-507. doi: 10.1074/jbc.M109.083337. Epub 2010 May 11.
10
MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.微小RNA-34a通过直接抑制JAG1/Notch1轴减轻前列腺癌细胞对紫杉醇的耐药性。
Cell Physiol Biochem. 2018;50(1):261-276. doi: 10.1159/000494004. Epub 2018 Oct 3.
引用本文的文献
1
Therapeutic connections between pyroptosis and paclitaxel in anti-tumor effects: an updated review.细胞焦亡与紫杉醇在抗肿瘤作用中的治疗联系：最新综述
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 21. doi: 10.1007/s00210-025-04036-8.
2
Biological functions and therapeutic potential of SRY related high mobility group box 5 in human cancer.SRY相关高迁移率族蛋白5在人类癌症中的生物学功能及治疗潜力
Front Oncol. 2024 May 21;14:1332148. doi: 10.3389/fonc.2024.1332148. eCollection 2024.
3
Advances in the role of microRNAs associated with the PI3K/AKT signaling pathway in lung cancer.与PI3K/AKT信号通路相关的微小RNA在肺癌中的作用进展
Front Oncol. 2023 Dec 19;13:1279822. doi: 10.3389/fonc.2023.1279822. eCollection 2023.
4
Role of microRNAs in regulation of doxorubicin and paclitaxel responses in lung tumor cells.微小RNA在调控肺肿瘤细胞对阿霉素和紫杉醇反应中的作用
Cell Div. 2023 Jul 21;18(1):11. doi: 10.1186/s13008-023-00093-8.
5
High expression of miR-107 and miR-17 predicts poor prognosis and guides treatment selection in acute myeloid leukemia.miR-107和miR-17的高表达预示急性髓系白血病预后不良并指导治疗选择。
Transl Cancer Res. 2023 Apr 28;12(4):913-927. doi: 10.21037/tcr-22-2484. Epub 2023 Mar 17.
6
Cell cycle associated miRNAs as target and therapeutics in lung cancer treatment.细胞周期相关的微小RNA作为肺癌治疗的靶点和疗法
Heliyon. 2022 Oct 13;8(10):e11081. doi: 10.1016/j.heliyon.2022.e11081. eCollection 2022 Oct.
7
Metformin up-regulated miR-107 expression and enhanced the inhibitory effect of miR-107 on gastric cancer growth.二甲双胍上调miR-107的表达，并增强了miR-107对胃癌生长的抑制作用。
Transl Cancer Res. 2020 Apr;9(4):2941-2950. doi: 10.21037/tcr.2020.03.25.
8
The rate of miR-146a rs2910164 mutations in patients with lung cancer: a meta-analytic review.肺癌患者中miR-146a rs2910164突变率：一项荟萃分析综述
Transl Cancer Res. 2020 Nov;9(11):6792-6800. doi: 10.21037/tcr-20-2171.
9
Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2/mTOR/P-gp pathway.外泌体 microRNA-107 通过 HMGA2/mTOR/P-gp 通路逆转胃癌细胞的化疗耐药性。
BMC Cancer. 2021 Dec 2;21(1):1290. doi: 10.1186/s12885-021-09020-y.
10
The role of vulpinic acid as a natural compound in the regulation of breast cancer-associated miRNAs.作为一种天然化合物，壬二酸在调节乳腺癌相关 miRNA 中的作用。
Biol Res. 2021 Nov 7;54(1):37. doi: 10.1186/s40659-021-00360-4.
本文引用的文献
1
MicroRNA-107 inhibits tumor growth and metastasis by targeting the BDNF-mediated PI3K/AKT pathway in human non-small lung cancer.微小RNA-107通过靶向脑源性神经营养因子介导的PI3K/AKT信号通路抑制人非小细胞肺癌的生长和转移。
Int J Oncol. 2016 Oct;49(4):1325-33. doi: 10.3892/ijo.2016.3628. Epub 2016 Jul 25.
2
Regulation of Skeletal Muscle by microRNAs.微小RNA对骨骼肌的调控
Compr Physiol. 2016 Jun 13;6(3):1279-94. doi: 10.1002/cphy.c150041.
3
MicroRNA-26b regulates cancer proliferation migration and cell cycle transition by suppressing TRAF5 in esophageal squamous cell carcinoma.微小RNA-26b通过抑制食管鳞状细胞癌中的TRAF5来调节癌症增殖、迁移和细胞周期转换。
Am J Transl Res. 2016 May 15;8(5):1957-70. eCollection 2016.
4
MicroRNA-320a promotes 5-FU resistance in human pancreatic cancer cells.微小RNA-320a促进人胰腺癌细胞对5-氟尿嘧啶的耐药性。
Sci Rep. 2016 Jun 9;6:27641. doi: 10.1038/srep27641.
5
MCL-1 is the key target of adjuvant chemotherapy to reverse the cisplatin-resistance in NSCLC.髓细胞白血病序列1（MCL-1）是辅助化疗逆转非小细胞肺癌顺铂耐药性的关键靶点。
Gene. 2016 Aug 10;587(2):147-54. doi: 10.1016/j.gene.2016.04.054. Epub 2016 Apr 29.
6
Downregulation of miR-129-2 by promoter hypermethylation regulates breast cancer cell proliferation and apoptosis.启动子高甲基化导致的miR-129-2下调调控乳腺癌细胞增殖与凋亡。
Oncol Rep. 2016 May;35(5):2963-9. doi: 10.3892/or.2016.4647. Epub 2016 Mar 2.
7
MicroRNA-205 increases the sensitivity of docetaxel in breast cancer.微小RNA-205增强乳腺癌对多西他赛的敏感性。
Oncol Lett. 2016 Feb;11(2):1105-1109. doi: 10.3892/ol.2015.4030. Epub 2015 Dec 11.
8
High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma.高 miR-34a 表达可改善弥漫性大 B 细胞淋巴瘤对多柔比星的反应。
Exp Hematol. 2016 Apr;44(4):238-46.e2. doi: 10.1016/j.exphem.2015.12.007. Epub 2016 Feb 17.
9
MicroRNAs: an emerging player in autophagy.微小RNA：自噬领域的新兴参与者。
ScienceOpen Res. 2015;2015. doi: 10.14293/S2199-1006.1.SOR-LIFE.A181CU.v1. Epub 2014 Dec 22.
10
MicroRNA-497 inhibits tumor growth and increases chemosensitivity to 5-fluorouracil treatment by targeting KSR1.微小RNA-497通过靶向KSR1抑制肿瘤生长并增强对5-氟尿嘧啶治疗的化学敏感性。
Oncotarget. 2016 Jan 19;7(3):2660-71. doi: 10.18632/oncotarget.6545.
Zotero 插件